Sorafenib plus hepatic arterial infusion chemotherapy versus sorafenib alone for advanced hepatocellular carcinoma: A systematic review and meta-analysis.
Journal of gastroenterology and hepatology（2023）
摘要
Sorafenib plus HAIC improved OS, PFS, and ORR compared with sorafenib alone in advanced HCC, with acceptable safety profile.
更多查看译文
关键词
combination therapy,hepatic arterial infusion chemotherapy,hepatocellular carcinoma,sorafenib
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要